Tolterodine Tartrate Capsule, Extended Release Shortage
Last Updated: February 26, 2025
Status: Discontinued
To Be Discontinued:
- Detrol LA, Capsule, Extended Release, 2 mg (Mylan Pharmaceuticals Inc., a Viatris Company)
- Detrol LA, Capsule, Extended Release, 4 mg (Mylan Pharmaceuticals Inc., a Viatris Company)
Detrol LA, Capsule, Extended Release, 2 mg (Mylan Pharmaceuticals Inc., a Viatris Company)
NDC Code: 58151-103-77Status: To Be Discontinued
Date of update: February 26, 2025
Update type: New
Therapeutic category: Urology
Date discontinued: February 26, 2025
Initial posting date: February 26, 2025
Contact info: 800-796-9526
Detrol LA, Capsule, Extended Release, 2 mg (Mylan Pharmaceuticals Inc., a Viatris Company)
NDC Code: 58151-103-93Status: To Be Discontinued
Date of update: February 26, 2025
Update type: New
Therapeutic category: Urology
Date discontinued: February 26, 2025
Initial posting date: February 26, 2025
Contact info: 800-796-9526
Detrol LA, Capsule, Extended Release, 4 mg (Mylan Pharmaceuticals Inc., a Viatris Company)
NDC Code: 58151-104-77Status: To Be Discontinued
Date of update: February 26, 2025
Update type: New
Therapeutic category: Urology
Date discontinued: February 26, 2025
Initial posting date: February 26, 2025
Contact info: 800-796-9526
Detrol LA, Capsule, Extended Release, 4 mg (Mylan Pharmaceuticals Inc., a Viatris Company)
NDC Code: 58151-104-93Status: To Be Discontinued
Date of update: February 26, 2025
Update type: New
Therapeutic category: Urology
Date discontinued: February 26, 2025
Initial posting date: February 26, 2025
Contact info: 800-796-9526
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.